ArticleScientific reports2025
Dual acid-base catalysis with biologically modified graphene oxide: a sustainable route to polyhydroquinolines with antimicrobial properties.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- A dendritic nanocatalyst (FeScientific reports · 2025Article
- Investigating the electronic properties of graphene oxide functionalized with benzoic acid.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This article conducts an in-depth examination of graphene oxide-aspartic acid (GO-As) as a novel bifunctional nano-organocatalyst distinguished by both catalytic and antibacterial properties. The research elucidates the synthesis of GO through Hummer's method, followed by the covalent attachment of aspartic acid to the surface of GO nanosheets. This innovative approach is particularly notable as it circumvents the use of hazardous chemicals, thereby promoting environmental sustainability. The newly developed catalyst underwent rigorous analysis employing a variety of spectroscopic techniques, including Fourier Transform Infrared (FT-IR) spectroscopy, Energy-Dispersive X-ray Spectroscopy (EDX), mapping, Field Emission Scanning Electron Microscopy (SEM), X-ray diffraction (XRD), thermogravimetric analysis (TGA), and Raman spectroscopy. The findings indicate that the catalyst effectively synthesizes polyhydroquinoline derivatives while demonstrating significant stability over multiple reuse cycles, underscoring its potential applicability in organic synthesis. Furthermore, the antibacterial properties of the GO-modified aspartic acid were evaluated against six pathogenic bacterial species. The results reveal substantial antibacterial activity against both Gram-positive and Gram-negative strains, including two antibiotic-resistant bacteria: Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus (VRE), thermogravimetric analysis (TGA), and Raman. In conclusion, the investigation of GO-As as a bifunctional heterogeneous nano-organocatalyst represents a promising advancement in the development of environmentally friendly and effective catalysts with noteworthy antibacterial characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.